The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
Primary Purpose
Intestinal Diseases
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Orange juice
Sponsored by
About this trial
This is an interventional basic science trial for Intestinal Diseases focused on measuring Orange juice, Microbiota, Prebiotic, Flavanones, Bioavailability
Eligibility Criteria
Inclusion Criteria:
Healthy women BMI 18.5 - 29.9 kg/m2.
Exclusion Criteria:
Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.
Sites / Locations
- Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Orange juice
Arm Description
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
Outcomes
Primary Outcome Measures
Total counting of aerobic bacteria and facultative anaerobic bacteria
Determination of butyric acid
Determination of acetic acid
Ammonium concentration
Secondary Outcome Measures
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
Body mass index
Body lean mass
Body fat mass
% body fat
Ratio waist/hip
Glucose
Insulin
Total cholesterol
Low density lipoprotein cholesterol
High density lipoprotein cholesterol
Triglycerides
hsCRP
Alkaline phosphatase
Aspartate enzyme aminotransferase
Alanine enzyme aminotransferase
GammaGT
Glycemic curve
Insulin curve
Full Information
NCT ID
NCT03032861
First Posted
January 6, 2017
Last Updated
April 25, 2017
Sponsor
São Paulo State University
1. Study Identification
Unique Protocol Identification Number
NCT03032861
Brief Title
The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
Official Title
Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
October 2016 (Actual)
Study Completion Date
February 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
São Paulo State University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.
Detailed Description
Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years). After 30 days, the participants will consume during 60 days 300 mL of orange juice daily. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones. The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017. The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015). The minimum sample size should have six individuals into the same group. Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women. Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production. Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces. Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively. One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day). P significance was set up ≤ 0.05.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intestinal Diseases
Keywords
Orange juice, Microbiota, Prebiotic, Flavanones, Bioavailability
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Orange juice
Arm Type
Experimental
Arm Description
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
Intervention Type
Other
Intervention Name(s)
Orange juice
Intervention Description
Thirty days before the beginning of trial, women (n= 10; BMI 23.8 kg/m2; 28 years) will be advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages. After 30 days, the participants will consume 300 mL of orange juice daily during 60 days. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and the bioavailability of its flavanones in blood, urine and feces.
Primary Outcome Measure Information:
Title
Total counting of aerobic bacteria and facultative anaerobic bacteria
Time Frame
4 months
Title
Determination of butyric acid
Time Frame
4 months
Title
Determination of acetic acid
Time Frame
4 months
Title
Ammonium concentration
Time Frame
4 mounths
Secondary Outcome Measure Information:
Title
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Description
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
Time Frame
4 months
Title
Body mass index
Time Frame
4 months
Title
Body lean mass
Time Frame
4 months
Title
Body fat mass
Time Frame
4 months
Title
% body fat
Time Frame
4 months
Title
Ratio waist/hip
Time Frame
4 mounths
Title
Glucose
Time Frame
4 mounths
Title
Insulin
Time Frame
4 mounths
Title
Total cholesterol
Time Frame
4 mounths
Title
Low density lipoprotein cholesterol
Time Frame
4 mounths
Title
High density lipoprotein cholesterol
Time Frame
4 mounths
Title
Triglycerides
Time Frame
4 mounths
Title
hsCRP
Time Frame
4 mounths
Title
Alkaline phosphatase
Time Frame
4 mounths
Title
Aspartate enzyme aminotransferase
Time Frame
4 mounths
Title
Alanine enzyme aminotransferase
Time Frame
4 mounths
Title
GammaGT
Time Frame
4 mounths
Title
Glycemic curve
Time Frame
4 mounths
Title
Insulin curve
Time Frame
4 mounths
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy women BMI 18.5 - 29.9 kg/m2.
Exclusion Criteria:
Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thais B Cesar, PhD
Organizational Affiliation
Sao Paulo State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas
City
Araraquara
State/Province
Sao Paulo
ZIP/Postal Code
14800-903
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.
Citations:
PubMed Identifier
25495754
Citation
Silveira JQ, Cesar TB, Manthey JA, Baldwin EA, Bai J, Raithore S. Pharmacokinetics of flavanone glycosides after ingestion of single doses of fresh-squeezed orange juice versus commercially processed orange juice in healthy humans. J Agric Food Chem. 2014 Dec 31;62(52):12576-84. doi: 10.1021/jf5038163. Epub 2014 Dec 15.
Results Reference
result
PubMed Identifier
11234459
Citation
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
Results Reference
result
PubMed Identifier
17047689
Citation
Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007 Apr;61(4):472-7. doi: 10.1038/sj.ejcn.1602543. Epub 2006 Oct 18.
Results Reference
result
Learn more about this trial
The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
We'll reach out to this number within 24 hrs